Brandon Ingram Remains Day-to-Day With Right Heel Inflammation in Playoff Context

Brandon Ingram is listed day-to-day with right heel inflammation — a designation that carries different weight in May than it would in January. This is playoff basketball, and "day-to-day" at this stage of the season almost always means a player is pushing through rather than sitting out.

Heel inflammation in an NBA context typically involves the retrocalcaneal bursa, the Achilles insertion, or the plantar fascia — the exact structure is inferred from reporting, not confirmed by imaging disclosure. All three share a common clinical profile in the short term: manageable with load reduction, anti-inflammatory treatment, and activity modification. Grade is inferred as Grade 1 (mild soft tissue irritation) based on the day-to-day designation and absence of any reported in-game event or escalating timeline language.

The more important clinical lens here is the playoff modifier. Per established NBA patterns, "day-to-day" in May effectively reads as "probable to play." Players and teams accept clinical risk in the postseason that they would not accept in March. Unless this designation escalates to Doubtful or Out — or unless there's a discrete in-game event that changes the picture — Ingram is expected to suit up.

The one flag worth watching: heel and hindfoot designations that persist across multiple playoff games without resolution can signal a deeper soft tissue load issue. The cumulative volume of playoff minutes on an already-irritated heel insertion can accelerate a Grade 1 presentation toward something more stubborn. If Ingram is visibly favoring the foot or his usage drops, that's worth tracking as a potential offseason storyline even if he plays through it now.

Updated on 2026-05-31: team corrected from "New Orleans Pelicans" to "Raptors" (legacy fact sweep, roster lookup player_id=6f15b9b8-67db-488e-beec-2aa529615713)